2016 European Guidelines on cardiovascular disease prevention in clinical practice
Tóm tắt
Từ khóa
Tài liệu tham khảo
A Dictionary of Epidemiology. 4th ed . New York: Oxford University Press.
NICE Public Health Guidance 25. Prevention of Cardiovascular Disease . http://www.nice.org.uk/guidance/PH25 .
World Health Organization. Global status report on non-communicable diseases 2010 . http://apps.who.int/iris/bitstream/10665/44579/1/9789240686458_eng.pdf .
Cobiac LJ , Magnus A , Lim S , Barendregt JJ , Carter R , Vos T . Which interventions offer best value for money in primary prevention of cardiovascular disease? PLoS One 2012;7:e41842.
Nichols M TN , Scarborough P , Rayner P . European Cardiovascular Disease Statistics, 2012 edition. http://www.escardio.org/static_file/Escardio/Press-media/press-releases/2013/EU-cardiovascular-disease-statistics-2012.pdf .
Mistry H , Morris S , Dyer M , Kotseva K , Wood D , Buxton M . Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach. BMJ Open 2012;2:e001029.
World Health Organization. Scaling up action agains noncommunicable diseases: how much will it cost? Geneva: World Health Organization, 2011.
Mason H , Shoaibi A , Ghandour R , O'Flaherty M , Capewell S , Khatib R , Jabr S , Unal B , Sozmen K , Arfa C , Aissi W , Ben Romdhane H , Fouad F , Al-Ali R , Husseini A , MedCHAMPS project team. A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries. PLoS One 2014;9:e84445.
O'Keeffe C , Kabir Z , O'Flaherty M , Walton J , Capewell S , Perry IJ . Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland. BMJ Open 2013;3:e002837.
Graham I , Atar D , Borch-Johnsen K , Boysen G , Burell G , Cifkova R , Dallongeville J , De Backer G , Ebrahim S , Gjelsvik B , Herrmann-Lingen C , Hoes A , Humphries S , Knapton M , Perk J , Priori SG , Pyorala K , Reiner Z , Ruilope L , Sans-Menendez S , Op Reimer WS , Weissberg P , Wood D , Yarnell J , Zamorano JL , Walma E , Fitzgerald T , Cooney MT , Dudina A , Vahanian A , Camm J , De Caterina R , Dean V , Dickstein K , Funck-Brentano C , Filippatos G , Hellemans I , Kristensen SD , McGregor K , Sechtem U , Silber S , Tendera M , Widimsky P , Zamorano JL , Altiner A , Bonora E , Durrington PN , Fagard R , Giampaoli S , Hemingway H , Hakansson J , Kjeldsen SE , Larsen ML , Mancia G , Manolis AJ , Orth-Gomer K , Pedersen T , Rayner M , Ryden L , Sammut M , Schneiderman N , Stalenhoef AF , Tokgozoglu L , Wiklund O , Zampelas A . European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007;14 (Suppl 2):S1–S113.
Si S , Moss JR , Sullivan TR , Newton SS , Stocks NP . Effectiveness of general practice-based health checks: a systematic review and meta-analysis. Br J Gen Pract 2014;64:e47–e53.
Ebrahim S , Taylor F , Ward K , Beswick A , Burke M , Davey Smith G . Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2011;1:CD001561.
Krogsboll LT , Jorgensen KJ , Gronhoj Larsen C , Gotzsche PC . General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev 2012;10:CD009009.
National Institute for Health and Care Excellence. Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease. London: National Institute for Health and Care Excellence, 2014.
American Heart Association. Heart-Health Screenings . http://www.heart.org/HEARTORG/Conditions/Heart-Health-Screenings_UCM_428687_Article.jsp#.VtxbjseZaPU .
Scottish Intercollegiate Guidelines Network. Risk estimation and the prevention of cardiovascular disease. A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network, 2007.
Chamnan P , Simmons RK , Khaw KT , Wareham NJ , Griffin SJ . Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study. BMJ 2010;340:c1693.
Grundy SM , Cleeman JI , Merz CN , Brewer HB Jr , Clark LT , Hunninghake DB , Pasternak RC , Smith SC Jr , Stone NJ . Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol 2004;24:e149–e161.
Williams M . Risk assessment and management of cardiovascular disease in New Zealand. N Z Med J 2003;116:U661.
Rabar S , Harker M , O'Flynn N , Wierzbicki AS , Guideline Development G . Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. BMJ 2014;349:g4356.
Board JBS . Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart 2014;100 (Suppl 2):ii1–ii67.
Pyorala, 1994, Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension, Eur Heart J, 15, 1300
World Health Organisation. WHO Global Health Repository. Cardiovascular diseases, deaths per 100 000. Data by country. http://apps.who.int/gho/data/node.main.A865CARDIOVASCULAR?lang=en .
Hughes MF , Saarela O , Stritzke J , Kee F , Silander K , Klopp N , Kontto J , Karvanen J , Willenborg C , Salomaa V , Virtamo J , Amouyel P , Arveiler D , Ferrieres J , Wiklund PG , Baumert J , Thorand B , Diemert P , Tregouet DA , Hengstenberg C , Peters A , Evans A , Koenig W , Erdmann J , Samani NJ , Kuulasmaa K , Schunkert H . Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohorts. PLoS One 2012;7:e40922.
Floyd CN , Mustafa A , Ferro A . The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis. PLoS One 2014;9:e101518.
Wang X , Falkner B , Zhu H , Shi H , Su S , Xu X , Sharma AK , Dong Y , Treiber F , Gutin B , Harshfield G , Snieder H . A genome-wide methylation study on essential hypertension in young African American males. PLoS One 2013;8:e53938.
Alter DA , Franklin B , Ko DT , Austin PC , Lee DS , Oh PI , Stukel TA , Tu JV . Socioeconomic status, functional recovery, and long-term mortality among patients surviving acute myocardial infarction. PLoS One 2014;8:e65130.
Desvarieux M , Demmer RT , Jacobs DR , Papapanou PN , Sacco RL , Rundek T . Changes in clinical and microbiological periodontal profiles relate to progression of carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology study. J Am Heart Assoc 2013;2:e000254.
Mishra, 2012, Exercise interventions on health-related quality of life for people with cancer during active treatment, Cochrane Database Syst Rev, 8, CD008465
Johns, 1991, A new method for measuring daytime sleepiness: the Epworth sleepiness scale, Sleep, 14, 540, 10.1093/sleep/14.6.540
World Health Organization. Familial hypercholesterolemia—report of a second WHO consultation. Geneva: World Health Organization, 1999.
Skjaerven R , Wilcox AJ , Klungsoyr K , Irgens LM , Vikse BE , Vatten LJ , Lie RT . Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study. BMJ 2012;345:e7677.
Bhopal RS , Humphry RW , Fischbacher CM . Changes in cardiovascular risk factors in relation to increasing ethnic inequalities in cardiovascular mortality: comparison of cross-sectional data in the Health Surveys for England 1999 and 2004. BMJ Open 2013;3:e003485.
Rubak, 2005, Motivational interviewing: a systematic review and meta-analysis, Br J Gen Pract, 55, 305
General Medical Council. Consent: patients and doctors making decisions together. Manchester, UK: General Medical Council, 2008.
Martin LR , DiMatteo MR , eds. The Oxford Handbook of Health Communication, Behaviour Change, and Treatment Adherence . New York: Oxford University Press, 2014.
U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed . Baltimore: Williams & Wilkins, 1996.
Glozier N , Christensen H , Naismith S , Cockayne N , Donkin L , Neal B , Mackinnon A , Hickie I . Internet-delivered cognitive behavioural therapy for adults with mild to moderate depression and high cardiovascular disease risks: a randomised attention-controlled trial. PLoS One 2013;8:e59139.
Ladwig KH , Lederbogen F , Albus C , Angermann C , Borggrefe M , Fischer D , Fritzsche K , Haass M , Jordan J , Junger J , Kindermann I , Kollner V , Kuhn B , Scherer M , Seyfarth M , Voller H , Waller C , Herrmann-Lingen C . Position paper on the importance of psychosocial factors in cardiology: update 2013. Ger Med Sci 2014;12:Doc09.
Page, 2005, Effectiveness of nurse-led cardiac clinics in adult patients with a diagnosis of coronary heart disease, Int J Evid Based Healthcare, 3, 2
Moore SC , Patel AV , Matthews CE , Berrington de Gonzalez A , Park Y , Katki HA , Linet MS , Weiderpass E , Visvanathan K , Helzlsouer KJ , Thun M , Gapstur SM , Hartge P , Lee IM . Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med 2012;9:e1001335.
Campbell F BL , Messina J , Day M , Buckley Wood H , Payne N , Goyder E , Armitage C . National Institute for Health and Clinical Excellence (NICE) public health intervention guidance physical activity: BA for adults in primary care. Review of effectiveness evidence . London: National Institute for Health and Clinical Excellence, 2012.
Garrett S , Elley CR , Rose SB , O'Dea D , Lawton BA , Dowell AC . Are physical activity interventions in primary care and the community cost-effective? A systematic review of the evidence. Br J Gen Pract 2011;61:e125–e133.
Physical Activity Guidelines Advisory Committee. Physical Activity Guidelines Advisory Committee Report, 2008 . Washington, DC: U.S. Department of Health and Human Services, 2008.
Department of Health, Physical Activity, Health Improvement and Protection. Stay Active: A report on physical activity for health from the four home countries' Chief Medical Officers . https://www.sportengland.org/media/388152/dh_128210.pdf .
Howley ET . Type of activity: resistance, aerobic and leisure versus occupational physical activity. Med Sci Sports Exerc 2001;33 (6 Suppl):S364–S369; discussion S419–S420.
American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription . Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health, 2014.
Cahill K , Stevens S , Perera R , Lancaster T . Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013;5:CD009329.
Hughes JR , Stead LF , Lancaster T . Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007;1:CD000031.
Cahill K , Stead LF , Lancaster T . Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012;4:CD006103.
Hughes JR , Stead LF , Hartmann-Boyce J , Cahill K , Lancaster T . Antidepressants for smoking cessation. Cochrane Database Syst Rev 2014;1:CD000031.
Taylor T LD , Bryant A , Keyse L , Joloza MT Smoking-related behaviour and attitudes, 2005 . London: Office for National Statistics, 2006.
West R . Key performance indicators: findings from the Smoking Toolkit Study . http://www.smokinginengland.info .
Centers for Disease Control and Prevention. How Tobacco Smoke Causes Disease: The Biology and Behavioural Basis for Smoking-attributable Disease 2010. A Report of the Surgeon General . http://www.surgeongeneral.gov/library/tobaccosmoke/index.html .
Critchley J , Capewell S . Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2004;1:CD003041.
Stead, 2008, Physician advice for smoking cessation, Cochrane Database Syst Rev, 2, CD000165
Stead LF , Perera R , Bullen C , Mant D , Hartmann-Boyce J , Cahill K , Lancaster T . Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012;11:CD000146.
McRobbie H , Bullen C , Hartmann-Boyce J , Hajek P . Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev 2014;12:CD010216.
European Heart Network. Diet, Physical Activity and Cardiovascular Disease Prevention in Europe . Brussels, Belguim: European Heart Network, 2011.
Wang X , Ouyang Y , Liu J , Zhu M , Zhao G , Bao W , Hu FB . Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ 2014;349:g4490.
Dauchet, 2006, Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies, J Nutr, 136, 2588, 10.1093/jn/136.10.2588
Chowdhury R , Kunutsor S , Vitezova A , Oliver-Williams C , Chowdhury S , Kiefte-de-Jong JC , Khan H , Baena CP , Prabhakaran D , Hoshen MB , Feldman BS , Pan A , Johnson L , Crowe F , Hu FB , Franco OH . Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014;348:g1903.
Ronksley PE , Brien SE , Turner BJ , Mukamal KJ , Ghali WA . Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 2011;342:d671.
Holmes MV , Dale CE , Zuccolo L , Silverwood RJ , Guo Y , Ye Z , Prieto-Merino D , Dehghan A , Trompet S , Wong A , Cavadino A , Drogan D , Padmanabhan S , Li S , Yesupriya A , Leusink M , Sundstrom J , Hubacek JA , Pikhart H , Swerdlow DI , Panayiotou AG , Borinskaya SA , Finan C , Shah S , Kuchenbaecker KB , Shah T , Engmann J , Folkersen L , Eriksson P , Ricceri F , Melander O , Sacerdote C , Gamble DM , Rayaprolu S , Ross OA , McLachlan S , Vikhireva O , Sluijs I , Scott RA , Adamkova V , Flicker L , Bockxmeer FM , Power C , Marques-Vidal P , Meade T , Marmot MG , Ferro JM , Paulos-Pinheiro S , Humphries SE , Talmud PJ , Mateo Leach I , Verweij N , Linneberg A , Skaaby T , Doevendans PA , Cramer MJ , van der Harst P , Klungel OH , Dowling NF , Dominiczak AF , Kumari M , Nicolaides AN , Weikert C , Boeing H , Ebrahim S , Gaunt TR , Price JF , Lannfelt L , Peasey A , Kubinova R , Pajak A , Malyutina S , Voevoda MI , Tamosiunas A , Maitland-van der Zee AH , Norman PE , Hankey GJ , Bergmann MM , Hofman A , Franco OH , Cooper J , Palmen J , Spiering W , de Jong PA , Kuh D , Hardy R , Uitterlinden AG , Ikram MA , Ford I , Hypponen E , Almeida OP , Wareham NJ , Khaw KT , Hamsten A , Husemoen LL , Tjonneland A , Tolstrup JS , Rimm E , Beulens JW , Verschuren WM , Onland-Moret NC , Hofker MH , Wannamethee SG , Whincup PH , Morris R , Vicente AM , Watkins H , Farrall M , Jukema JW , Meschia J , Cupples LA , Sharp SJ , Fornage M , Kooperberg C , LaCroix AZ , Dai JY , Lanktree MB , Siscovick DS , Jorgenson E , Spring B , Coresh J , Li YR , Buxbaum SG , Schreiner PJ , Ellison RC , Tsai MY , Patel SR , Redline S , Johnson AD , Hoogeveen RC , Hakonarson H , Rotter JI , Boerwinkle E , de Bakker PI , Kivimaki M , Asselbergs FW , Sattar N , Lawlor DA , Whittaker J , Davey Smith G , Mukamal K , Psaty BM , Wilson JG , Lange LA , Hamidovic A , Hingorani AD , Nordestgaard BG , Bobak M , Leon DA , Langenberg C , Palmer TM , Reiner AP , Keating BJ , Dudbridge F , Casas JP . Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ 2014;349:g4164.
World Health Organization. Guideline: Sugars Intake for Adults and Children . Geneva: World Health Organization, 2015.
Fruchart JC , Sacks F , Hermans MP , Assmann G , Brown WV , Ceska R , Chapman MJ , Dodson PM , Fioretto P , Ginsberg HN , Kadowaki T , Lablanche JM , Marx N , Plutzky J , Reiner Z , Rosenson RS , Staels B , Stock JK , Sy R , Wanner C , Zambon A , Zimmet P . The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol 2008;102 (10 Suppl):1K–34K.
Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499
Sharp Collaborative Group. Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. Am Heart J 2010;160:p785–794.e10.
Palmer SC , Navaneethan SD , Craig JC , Johnson DW , Perkovic V , Hegbrant J , Strippoli GF . HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev 2014;5:CD007784.
Reiner, 2005, [Concomitant use of statins and cytochrome P 450 inhibitors in Croatia], Lijecnicki vjesnik, 127, 65
Cholesterol Treatment Trialists' Collaboration, Emberson JR, Kearney PM, Blackwell L, Newman C, Reith C, Bhala N, Holland L, Peto R, Keech A, Collins R, Simes J, Baigent C. Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One 2012;7:e29849.
De Berardis G , Sacco M , Strippoli GF , Pellegrini F , Graziano G , Tognoni G , Nicolucci A . Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ 2009;339:b4531.
Preiss D , Sattar N , McMurray JJ . A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design. Am Heart J 2011;161:p210–219.e1.
Livingstone SJ , Looker HC , Hothersall EJ , Wild SH , Lindsay RS , Chalmers J , Cleland S , Leese GP , McKnight J , Morris AD , Pearson DW , Peden NR , Petrie JR , Philip S , Sattar N , Sullivan F , Colhoun HM . Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med 2012;9:e1001321.
Law MR , Morris JK , Wald NJ . Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665.
Feres, 2013, Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial, JAMA, 310, 2510
De Schryver, 2007, Dipyridamole for preventing stroke and other vascular events in patients with vascular disease, Cochrane Database Syst Rev, 3, CD001820
Liu, 2000, Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack, Cochrane Database Syst Rev, 2, CD000248
ASCEND. A Study of Cardiovascular Events in Diabetes . http://www.ctsu.ox.ac.uk/ascend .
Nelson, 2008, Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study, Med J Aust, 189, 105, 10.5694/j.1326-5377.2008.tb01932.x
Aspirin to Reduce Risk of Initial Vascular Events (ARRIVE) Trial . http://www.arrive-study.com .
de Cates AN , Farr MR , Wright N , Jarvis MC , Rees K , Ebrahim S , Huffman MD . Fixed-dose combination therapy for the prevention of cardiovascular disease. Cochrane Database Syst Rev 2014;4:CD009868.
National Institute for Health and Care Excellence. Prevention of cardiovascular disease at the population level. London: National Institute for Health and Care Excellence, 2010.
EU platform on diet, physical activity and health. European Union, 2005. http://ec.europa.eu/health/archive/ph_determinants/life_style/nutrition/platform/docs/platform_charter.pdf
Bureau Europe'en des Unions de Consommateurs. The consumer case for EU legal restrictions on the use of artificial trans-fats in food. Position paper. Brussels: European Union, 2014. http://www.beuc.eu/publications/beuc-x-2014-010_the_consumer_case_for_eu_legal_restrictions_on_the_use_of_artificial_trans.pdf .
He FJ , Pombo-Rodrigues S , Macgregor GA . Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open 2014;4:e004549.
Eyles H , Ni Mhurchu C , Nghiem N , Blakely T . Food pricing strategies, population diets, and non-communicable disease: a systematic review of simulation studies. PLoS Med 2012;9:e1001353.
Kriemler S , Zahner L , Schindler C , Meyer U , Hartmann T , Hebestreit H , Brunner-La Rocca HP , van Mechelen W , Puder JJ . Effect of school based physical activity programme (KISS) on fitness and adiposity in primary schoolchildren: cluster randomised controlled trial. BMJ 2010;340:c785.
Global Advocacy Council for Physical Activity, International Society for Physical Activity and Health. The Toronto Charter for Physical Activity: a global call for action. J Physical Activity Health 2010;7 (Suppl 3):S370–S385.
Exercise prescription for health—the green prescription . Dublin: RCSI House, 2013.
Huhman, 2007, Evaluation of a national physical activity intervention for children: VERB campaign, 2002–2004, Am J Prev Med, 32, 38, 10.1016/j.amepre.2006.08.030
American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription. 9th ed . Baltimore: Wolters Kluwer/Lippincott, 2014.
Leyk, 2014, Results of a workplace health campaign: what can be achieved?, Dtsch Arztebl Int, 111, 320
World Health Organization. Guidelines for implementation. WHO Framework Convention on Tobacco Control. Articles 5.3, 8–14. Geneva: World Health Organization, 2011.
International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks to humans. Volume 100E. Personal Habits and Indoor Combustions. Smokeless Tabacco . 2012 [http://monographs.iarc.fr/ENG/Monographs/vol100E/mono100E-8.pdf].
World Health Organization. Global status report on alcohol and health. http://apps.who.int/iris/bitstream/10665/112736/1/9789240692763_eng.pdf .
National Institute for Health and Care Excellence. Alcohol-use disorders: preventing the development of hazardous and harmful drinking . https://www.nice.org.uk/guidance/ph24 .
Stockwell T . A review of research into the impacts of alcohol warning labels on attitudes and behaviour. British Colombia, Canada: Center for Addiction Research of BC, University of Victoria, 2006.
Kaner EF , Beyer F , Dickinson HO , Pienaar E , Campbell F , Schlesinger C , Heather N , Saunders J , Burnand B . Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev 2007;2:CD004148.
Murphy AW , Cupples ME , Smith SM , Byrne M , Byrne MC , Newell J . Effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomised controlled trial. BMJ 2009;339:b4220.
Byrne, 2015, A survey of GPs awareness and use of risk assessment tools and cardiovascular disease prevention guidelines, Irish Med J, 108, 204
Anderson L , Taylor RS . Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev 2014;12:CD011273.
Karmali KN , Davies P , Taylor F , Beswick A , Martin N , Ebrahim S . Promoting patient uptake and adherence in cardiac rehabilitation. Cochrane Database Syst Rev 2014;6:CD007131.
Taylor RS , Dalal H , Jolly K , Moxham T , Zawada A . Home-based versus centre-based cardiac rehabilitation. Cochrane Database Syst Rev 2010;1:CD007130.